Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-22-016226)

Filing Details

Accession Number:: 0001493152-22-016226
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-09 06:04:33
Reporting Period:: 2022-06-07

Accepted Time:: 2022-06-09 06:04:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1574094	Renovorx Inc.	RNXT	Pharmaceutical Preparations (2834)	271448452

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1862617	Ramtin Agah	C/O Renovorx, Inc., 4546 El Camino Real, Suite B1 Los Altos, CA 94022	Chief Medical Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-03-16	975,000	$0.00	1,295	No	5	G	Direct
Common Stock	Acquisiton	2022-03-16	975,000	$0.00	975,000	No	5	G	Indirect	See footnote
Common Stock	Acquisiton	2022-06-07	5,182	$1.93	6,477	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	See footnote
No	4	P	Direct

Footnotes

The shares are held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016.